EPISODE · Dec 17, 2024 · 18 MIN
Dana Rizk, MD - Unlocking the Potential of B-Cell Modulation Therapies in IgA Nephropathy
from PeerVoice Internal Medicine Audio · host PeerVoice
Dana Rizk, MD - Unlocking the Potential of B-Cell Modulation Therapies in IgA Nephropathy
What this episode covers
Visit https://www.peervoice.com/NEX860 to view the entire programme with slides. After completing “Dana Rizk, MD - Unlocking the Potential of B-Cell Modulation Therapies in IgA Nephropathy”, participants will be able to: Outline the role of Gd-IgA1 and specific immune-mediated mechanisms in the pathophysiology of IgA nephropathy (IgAN); Summarize the relationship between key predictors of long-term outcome and their role in assessing risk of progression in patients with IgAN; Describe the role of different immune-specific targets in IgAN; and Evaluate clinical data regarding therapies targeting immune-specific mediators of disease in patients with IgAN.
NOW PLAYING
Dana Rizk, MD - Unlocking the Potential of B-Cell Modulation Therapies in IgA Nephropathy
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Feb 8, 2026 ·4m
Jan 30, 2026 ·6m
Jan 2, 2026 ·47m